Thrombolysis in an acute ischemic stroke patient with rivaroxaban anticoagulation: A case report

RATIONALE: Whether intravenous recombinant tissue plasminogen activator (r-TPA) therapy can be administered in acute ischemic stroke patients treated with novel oral anticoagulants (NOACs), including rivaroxaban, remains controversial. PATIENT CONCERNS: A 76-year-old woman with nonvalvular atrial fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Yen-Tung, Hu, Chaur-Jong, Chan, Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408142/
https://www.ncbi.nlm.nih.gov/pubmed/30813169
http://dx.doi.org/10.1097/MD.0000000000014560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408142/
https://www.ncbi.nlm.nih.gov/pubmed/30813169
http://dx.doi.org/10.1097/MD.0000000000014560

Ejemplares similares